S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Cell Therapeutics Reports Second Quarter 2013 Financial Results ()|
|Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results (2014/3/4)|
|BrainStorm Cell Therapeutics Will Host a Conference Call to Update Shareholders on Recent Company Developments ()|
|BrainStorm Cell Therapeutics Will Host a Conference Call to Update Shareholders on Recent Positive Company Developments ()|
|Baxter, Cell Therapeutics Sign Licensing Agreement ()|
|BrainStorm Cell Therapeutics Presents at the 24th International Symposium on ALS/MND (2013/12/5)|
|Cell Therapeutics to Present at the 26th Annual ROTH Conference (2014/3/5)|
|Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib ()|
|BrainStorm Receives $800,000 Non-Dilutive Grant from Israel’s Office of the Chief Scientist (2013/12/11)|
|Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI® (pixantrone) in Germany ()|
Click above to view more mutual fund data and stats for 0q9g - Cell Therapeutics Inc.